Founded in May 1998, Jilin Zixin Pharmaceutical Industrial Co., Ltd. is a high-tech joint-stock company that combines the three major industries of proprietary Chinese medicines, ginseng, and gene sequencer. It also integrates research, production, sales, and breeding and planting of pharmaceutical animals and plants.
nearly 5500OTC control team members
20 years of industry experience
nearly 180,000 companies for terminal cooperation
(176,000 retail terminals;
3,000 medical units)
205 drug approval numbers
Cultivating people’s virtue, Producing drugs with professional ethics
Upholding the company philosophy of cultivating people’s virtue and producing drugs with professional ethics, the company aims at modernizing traditional Chinese medicine and improving human health.
"Zixin" trademark was rated as China's well-known trademark
We have been honored as "National Top 100 Pharmaceutical Enterprise", "National High-tech Enterprise", "National-level Key Agricultural Industrialization Leading Enterprise", and "National Contract-keeping Enterprise". Additionally, "Zixin" trademark was rated as China's well-known trademark.
The stock code is "002118"
The company now has more than 10 branches and subsidiaries, and more than 2,000 employees. We are now a large-scale pharmaceutical listed group with a total market value of nearly 10 billion yuan.
Build a hundred years of ZiXin and create a national brand
we will build a big health industry ecosystem with “science and technology innovation” as our core competitiveness. We are working hard towards the grand goal of “building a hundred years of Zixin and creating national brands”!